Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$38.79 - $43.16 $207,448 - $230,819
-5,348 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$36.52 - $41.46 $195,308 - $221,728
5,348 New
5,348 $213,000
Q1 2021

May 17, 2021

SELL
$34.27 - $40.01 $209,492 - $244,581
-6,113 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$34.07 - $39.94 $218,184 - $255,775
-6,404 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$38.11 - $42.99 $18,597 - $20,979
-488 Reduced 7.08%
6,404 $241,000
Q2 2020

Aug 13, 2020

SELL
$37.87 - $43.58 $28,629 - $32,946
-756 Reduced 9.88%
6,892 $281,000
Q1 2020

May 14, 2020

BUY
$32.47 - $48.83 $23,313 - $35,059
718 Added 10.36%
7,648 $290,000
Q4 2019

Feb 13, 2020

SELL
$42.0 - $48.25 $54,936 - $63,111
-1,308 Reduced 15.88%
6,930 $326,000
Q3 2019

Nov 13, 2019

SELL
$40.46 - $43.52 $138,009 - $148,446
-3,411 Reduced 29.28%
8,238 $352,000
Q2 2019

Aug 13, 2019

SELL
$39.4 - $42.7 $132,384 - $143,472
-3,360 Reduced 22.39%
11,649 $466,000
Q1 2019

May 14, 2019

BUY
$38.57 - $42.69 $42,234 - $46,745
1,095 Added 7.87%
15,009 $627,000
Q4 2018

Feb 13, 2019

SELL
$37.8 - $42.69 $228,425 - $257,975
-6,043 Reduced 30.28%
13,914 $532,000
Q3 2018

Nov 13, 2018

SELL
$39.75 - $42.69 $106,609 - $114,494
-2,682 Reduced 11.85%
19,957 $802,000
Q2 2018

Aug 13, 2018

SELL
$39.61 - $42.76 $208,546 - $225,131
-5,265 Reduced 18.87%
22,639 $913,000
Q1 2018

May 14, 2018

BUY
$36.18 - $40.15 $81,658 - $90,618
2,257 Added 8.8%
27,904 $1.09 Million
Q4 2017

Feb 13, 2018

BUY
$35.34 - $41.9 $48,981 - $58,073
1,386 Added 5.71%
25,647 $910,000
Q3 2017

Nov 13, 2017

BUY
$39.44 - $41.55 $956,853 - $1.01 Million
24,261
24,261 $985,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $68.1B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Epoch Investment Partners, Inc. Portfolio

Follow Epoch Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Epoch Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Epoch Investment Partners, Inc. with notifications on news.